Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Team Novo Nordisk Adds Five New Riders to 2019 Pro Roster

The world's first all-diabetes pro cycling team brings in an Olympian and advances four riders from its development squad while adding changes to its GSG-designed jersey


News provided by

Team Novo Nordisk

Dec 11, 2018, 08:05 ET

Share this article

Share toX

Share this article

Share toX

Team Novo Nordisk's 2019 men's professional team
Team Novo Nordisk's 2019 men's professional team

ATLANTA, Dec. 11, 2018 /PRNewswire-PRWeb/ -- Team Novo Nordisk, the world's first all-diabetes pro cycling team, will race its seventh season with 16 athletes from a dozen countries. The five new riders joining the team include Olympian and three-time former Hungarian national champion Peter Kusztor (HUN), Oliver Behringer (SUI), Declan Irvine (AUS), Sam Munday (AUS) and Ulugbek Saidov (UZB). Both Behringer and Irvine raced as stagiaires with the men's professional team during the 2018 season.

"I want to say a big thanks and congratulations to the 2018 squad. We had one victory, seven podiums, and 11 top five finishes, which are the most in Team Novo Nordisk's six-year history. This success was the combined result of confidence and teamwork," Team Novo Nordisk's CEO and Co-Founder Phil Southerland said. "Looking to 2019, I'm confident this trend will continue, and the addition of four development riders and veteran pro Peter Kusztor will serve as tremendous boosts for the team."

"A big thanks and congratulations to the 2018 squad. We had one victory, seven podiums, and 11 top five finishes--the most in Team Novo Nordisk's six-year history. This success was the combined result of confidence and teamwork. We are going into 2019 hungry for success," Phil Southerland said.

Post this

All athletes on Team Novo Nordisk race with type 1 diabetes. Since its launch in December 2012, the organization has focused heavily on identifying and developing endurance athletes from around the world with diabetes, which has lead to an extensive junior and development program where riders have the opportunity to advance to the men's professional team.

"Since our inception, we've set high standards for this program. To maintain this momentum, it is critical to move up this young generation of talented athletes with diabetes to the professional team," Team Novo Nordisk Senior Vice President of Athletics Vassili Davidenko said. "Our entire project is designed to provide them with as many opportunities as possible to succeed. We consciously blend our race rosters, so the neo-pros race alongside experienced veterans. This keeps motivation and moral high because the young riders are so eager to learn. Additionally, it provides all our riders with direction so they can continue to progress in a step-by-step manner."

Four of Team Novo Nordisk's five new athletes are products of its development program. Behringer, Irvine, Munday, and Saidov all spent at least two seasons racing as a part of the team's development pipeline. Saidov is Team Novo Nordisk's first professional rider from Central Asia.

For the first time in its history, Team Novo Nordisk is adding a new rider to its professional roster from outside of its development pipeline. Kusztor was recently diagnosed with type 1 diabetes after breaking his collarbone at the Czech Cycling Tour (August 2018). Before going in for surgery, doctors checked his fasting blood glucose levels and discovered they were elevated. Eventually, endocrinologists ran a series of tests and diagnosed the 33-year-old with type 1 diagnosis. Accolades over his 14-year career include representing Hungary at the 2008 Beijing Olympic Games, two-time Hungary national road race champion (2010, 2012), Hungary national time trial champion (2010), winner overall at the Tour of Bretagne (2011), second overall at Gemenc GP (2017) and lining up for four UCI Road World Championships (2008, 2009, 2012, 2013).

"Our returning riders have another season of racing in the pro peloton and our stagiaires impressed me these past few races. They showed significant improvements by the end of the year," Davidenko said. "We have big expectations in Kusztor and are proud to add him to our roster. I expect the entire project will be stronger in 2019."

Team Novo Nordisk's new 2019 GSG-designed jersey will feature repeating white text with the words 'inspire, educate and empower' down the torso below a light blue circle that serves as the global symbol for diabetes awareness. The navy blue jersey will continue to feature the words "Changing Diabetes" across the chest. The 2019 changes will continue to bring awareness to Team Novo Nordisk's mission to inspire, educate and empower everyone affected by diabetes.

"We are going into 2019 hungry for success. We just finished a pre-season training camp, and our riders' fitness is ahead of schedule compared to 2017," Southerland said. "I trust that our riders, coaches and medical staff will continue to build on this foundation and this growth with translate into success on the road, which allows us to have an even greater impact alongside Novo Nordisk to continue changing diabetes around the world."

The 2018 season saw Team Novo Nordisk achieve its best results to date, including 11 top five finishes and seven podium appearances. David Lozano (ESP) earned the team's second victory when he soloed to win Stage 7 of the Tour du Rwanda. The Spaniard had a standout season that saw him collect 10 top 10 finishes including fifth overall at the Tour of Estonia, fifth overall at the Tour du Rwanda and the KOM jersey following Stage 3 of the Vuelta Aragon. Frenchman Quentin Valognes, who now functions as an ambassador for the team, took home the Intermediate Sprint Jersey at the Dubai Tour while fellow Frenchman Charles Planet earned the Fighter's Jersey on Stage 3 of the PostNord Danmark Rundt and wore the Sprint leader's jersey on Stage 1 of the Tour of Hongrie. Planet also stood on the podium after finishing runner-up on the Tour of Hongrie Prologue.

"Looking towards 2019, our focus continues to be on developing our riders, so that they can be competitive at the top level of the sport. We do this by racing in many countries and at various levels all with the aim to provide hope and inspiration for everyone affected by diabetes," Davidenko said.

Team Novo Nordisk's full 2019 roster includes:

  • Oliver Behringer - SUI
  • Mehdi Benhamouda - FRA
  • Sam Brand - GBR (IMN)
  • Fabio Calabria - AUS
  • Stephen Clancy – IRL
  • Joonas Henttala – FIN
  • Declan Irvine - AUS
  • Brian Kamstra – NED
  • Peter Kusztor - HUN
  • David Lozano – ESP
  • Emanuel Mini – ARG
  • Sam Munday - AUS
  • Andrea Peron – ITA
  • Charles Planet – FRA
  • Umberto Poli – ITA
  • Ulugbek Saidov - UZB

About Team Novo Nordisk
Team Novo Nordisk is a global all-diabetes sports team of cyclists spearheaded by the world's first all-diabetes UCI Professional Continental cycling team. In 2012, Phil Southerland, co-founder and CEO of the team, and global healthcare company Novo Nordisk, came together to create Team Novo Nordisk, based on a shared vision to inspire, educate and empower people around the world affected by diabetes. For more information, go to http://www.teamnovonordisk.com.

Press contact:
Fitzalan Crowe
fitzalan.crowe(at)teamnovonordisk.com
US: +1-703-596-2020
Belgium: +32 493 17 57 66

SOURCE Team Novo Nordisk

Related Links

www.teamtype1.org

Modal title

Team Novo Nordisk's 2019 GSG-designed jersey
Team Novo Nordisk's 2019 GSG-designed jersey
Team Novo Nordisk's 2019 GSG-designed jersey

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.